中国药物经济学2025，Vol.20Issue(8)：13-18,6.DOI:10.12010/j.issn.1673-5846.2025.08.002
药品带量采购政策对连云港头部化药企业创新活动的影响
Influence of Drug Procurement Policy on the Innovation Activities of Lianyungang Head Chemical Drug Enterprises
摘要
Abstract
Objective To explore the influence of drug procurement policy on innovation activities of leading chemical drug enterprises in Lianyungang.Methods Jiangsu Hengrui Pharmaceutical Company,Sino Biopharmaceutical Limited,and Hansoh pharma were selected as the research objects in this paper to analyze the influence of volume procurement policy on the innovation activities of pharmaceutical companies from the aspects of corporate revenue,sales expenses,R&D investment,application of generic and innovative drugs,number of patent authorization,and number of R&D personnel.Results Post-policy implementation,corporate revenue exhibited growth with divergent trends:Sino Biopharmaceutical maintained stable revenue,while Hengrui and Hansoh experienced negative growth in 2021-2022 due to plummeting generic drug revenue.Sales expenses continued rising,primarily driven by intensified promotion of innovative drugs.R&D investment and its revenue share increased significantly,though Hengrui and Hansoh showed reduced R&D spending in 2022.Innovation output surged,evidenced by a sharp rise in innovative drug applications,a 3-4 fold increase in patent authorizations by 2022 compared to 2018,and expanded R&D teams.Divergent generic drug strategies emerged:Hengrui and Hansoh drastically reduced generic drug applications and revenue share,whereas Sino Biopharmaceutical sustained generic drug development and revenue growth.Conclusion The volume-based procurement policy significantly stimulated short-term innovation input and output among Lianyungang's leading chemical enterprises,reflected in elevated R&D intensity,surging innovative drug pipelines,and enhanced patent productivity.However,sustained innovation faces challenges from profit compression and persistently high sales expenses.Long-term innovation sustainability requires policy coordination and strategic upgrades by enterprises.关键词
药品带量采购/化药企业/创新活动Key words
Drug procurement policy/Chemical pharmaceutical enterprise/Innovation activity分类
医药卫生引用本文复制引用
何文萱,李雪,周越..药品带量采购政策对连云港头部化药企业创新活动的影响[J].中国药物经济学,2025,20(8):13-18,6.基金项目
中国商业会计学会职业教育分会科研课题(2024ZJ021) （2024ZJ021）
江苏财会职业学院教改课题(2023jsckjg14) （2023jsckjg14）
江苏财会职业学院校级科研课题(2023XJ04) （2023XJ04）
2023年全国中药特色技术传承人才培训项目(国中医药人教函[2023]96号) （国中医药人教函[2023]96号）
江苏省中药骨干人才高级研修项目(苏中医科教[2022]17号) （苏中医科教[2022]17号）
国家中医药管理局2022年全国名老中医药专家(蔡宝昌)传承工作室建设项目(国中医药人教函[2022]75号) （蔡宝昌）
